Ferring Pharmaceuticals, Inc.: FDA filings under this applicant name
FDA lists 0 510(k) clearances under the applicant name “Ferring Pharmaceuticals, Inc.”, plus 1 PMA decision, across 1 product code in 1 review panel. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| MOZ | Acid, Hyaluronic, Intraarticular | 1 | 0 |
Review panels
- Orthopedic (1)
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P010029 | PMA | EUFLEXXA (1% SODIUM HYALURONATE) | 2004-12-03 |
Recalls
1 product recalls in 1 recall events; 0 initiated in the last five years. Most recent: 2010-04-16.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Ferring Pharmaceuticals, Inc. is the lead sponsor of 5 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT03028415: AMPLEX Ankle Fusion and Hindfoot (Completed, started 2017-07-28)
- NCT00988091: Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee (Completed, started 2009-09)
- NCT01306357: Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device (Completed, started 2007-09)
- NCT00423371: Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC (Completed, started 2006-12)
- NCT00379236: A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee (Completed, started 2006-10)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Ferring Laboratories, Inc. (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Ferring Pharmaceuticals, Inc.?
FDA lists 0 510(k) clearances under the applicant name “Ferring Pharmaceuticals, Inc.”, plus 1 PMA decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
Which FDA product codes appear under Ferring Pharmaceuticals, Inc.?
The most frequent FDA product codes under this applicant name are MOZ (Acid, Hyaluronic, Intraarticular, 1).
Next steps
- See all 0 Ferring Pharmaceuticals, Inc. clearances with predicates and recalls
- Run predicate analysis for product code MOZ, Ferring Pharmaceuticals, Inc.'s most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.